All the fuss surrounding the proposal by India and South Africa to suspend the TRIPS Agreement to help them produce vaccines to fight COVID-19 has obscured some critical truths. In spite of the rallying cry “Patents versus People,” it’s not really about patents. And merely lifting TRIPS obligations will do nothing to address the current suffering of the world’s poorer populations. In fact, it would hamper efforts to secure global distribution of vaccines, as well as cause real harm in the long term.
Recent Posts
- Other Barks & Bites for Friday, November 8: Judge Dismisses Copyright Lawsuit Against OpenAI Filed by News Outlets; Reports Finds Record Number of Global Patent Filings; ITC Finds Semiconductor Company Infringed on Competitor’s Patent
- How Bayh-Dole Supporters Made a Successful Goal Line Stand
- How Recent Patent Damages Precedent May Increase Reasonable Royalty Awards
- The Judge Newman Story in Her Own Words: IPWatchdog Unleashed
- Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor